You are here: All Products  > Dizal Approved to Launch EGFR Inhibitor for NSCLC with Exon 20 Mutations

Dizal Approved to Launch EGFR Inhibitor for NSCLC with Exon 20 Mutations

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/downloading for seven days.